BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10648935)

  • 1. Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice.
    Newton DL; Pollock D; DiTullio P; Echelard Y; Harvey M; Wilburn B; Williams J; Hoogenboom HR; Raus JC; Meade HM; Rybak SM
    J Immunol Methods; 1999 Dec; 231(1-2):159-67. PubMed ID: 10648935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and cytotoxicity of a human pancreatic RNase immunofusion.
    Zewe M; Rybak SM; Dübel S; Coy JF; Welschof M; Newton DL; Little M
    Immunotechnology; 1997 Jun; 3(2):127-36. PubMed ID: 9237097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanization of immunotoxins.
    Rybak SM; Hoogenboom HR; Meade HM; Raus JC; Schwartz D; Youle RJ
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3165-9. PubMed ID: 1565609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
    Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
    Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice.
    Limonta J; Pedraza A; Rodríguez A; Freyre FM; Barral AM; Castro FO; Lleonart R; Gracía CA; Gavilondo JV; de la Fuente J
    Immunotechnology; 1995 Aug; 1(2):107-13. PubMed ID: 9373339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
    Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
    J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of the human hepatocarcinoma-intestine-pancreas/pancreatic-associated protein (HIP/PAP) gene in the mammary gland of lactating transgenic mice. Secretion into the milk and purification of the HIP/PAP lectin.
    Christa L; Pauloin A; Simon MT; Stinnakre MG; Fontaine ML; Delpal S; Ollivier-Bousquet M; Bréchot C; Devinoy E
    Eur J Biochem; 2000 Mar; 267(6):1665-71. PubMed ID: 10712597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interaction between S*tag and S*protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery.
    Asai T; Wims LA; Morrison SL
    J Immunol Methods; 2005 Apr; 299(1-2):63-76. PubMed ID: 15914191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casein gene expression: from transfection to transgenics.
    Greenberg NM; Wolfe J; Rosen JM
    Cancer Treat Res; 1992; 61():379-97. PubMed ID: 1360241
    [No Abstract]   [Full Text] [Related]  

  • 10. The recombinant chimeric antibody chHAb18 against hepatocellular carcinoma can be produced in milk of transgenic mice.
    Wei J; Yang X; Zheng M; Wang M; Dai Y; Chen Z; Li N
    Transgenic Res; 2011 Apr; 20(2):321-30. PubMed ID: 20549347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary gland tumor in transgenic mice expressing targeted beta-casein/HPV16E6 fusion gene.
    Hwang DY; Chae KR; Shin DH; Jang IS; Hwang JH; Kim YJ; Cho JY; Kim BJ; Goo JS; Lim CJ; Kim CK; Cho YY; Paik SG; Kim YK; Cho JS
    Int J Oncol; 2000 Dec; 17(6):1093-8. PubMed ID: 11078793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
    Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
    Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland.
    Niavarani A; Dehghanizadeh S; Zeinali S; Karimi M; Magliano M; Rassoulzadegan M
    Transgenic Res; 2005 Oct; 14(5):719-27. PubMed ID: 16245163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary gland-specific secretion of biologically active immunosuppressive agent cytotoxic-T-lymphocyte antigen 4 human immunoglobulin fusion protein (CTLA4Ig) in milk by transgenesis.
    Lui VC; Tam PK; Leung MY; Lau JY; Chan JK; Chan VS; Dallman M; Cheah KS
    J Immunol Methods; 2003 Jun; 277(1-2):171-83. PubMed ID: 12799049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human gamma-interferon expression in the mammary gland of transgenic mice.
    Dobrovolsky VN; Lagutin OV; Vinogradova TV; Frolova IS; Kuznetsov VP; Larionov OA
    FEBS Lett; 1993 Mar; 319(1-2):181-4. PubMed ID: 8454053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit whey acidic protein gene upstream region controls high-level expression of bovine growth hormone in the mammary gland of transgenic mice.
    Thépot D; Devinoy E; Fontaine ML; Stinnakre MG; Massoud M; Kann G; Houdebine LM
    Mol Reprod Dev; 1995 Nov; 42(3):261-7. PubMed ID: 8579839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and expression of a chimeric antibody directed against the human transferrin receptor.
    Hoogenboom HR; Raus JC; Volckaert G
    J Immunol; 1990 Apr; 144(8):3211-7. PubMed ID: 2324499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk.
    Tomasetto C; Wolf C; Rio MC; Mehtali M; LeMeur M; Gerlinger P; Chambon P; Lathe R
    Mol Endocrinol; 1989 Oct; 3(10):1579-84. PubMed ID: 2481815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.
    Shinohara H; Fan D; Ozawa S; Yano S; Van Arsdell M; Viner JL; Beers R; Pastan I; Fidler IJ
    Int J Oncol; 2000 Oct; 17(4):643-51. PubMed ID: 10995873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM; Leder P
    Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.